Sign in

CIK 0001878313

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAIA Biotechnology, Inc.

Sign in to watch
Ticker
MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 312-416-8592
Business address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
  1. 4 Open-market buy Director bought 10,000 shares at $3.74 ($37,400)
  2. 4 Open-market buy Director bought 1,263 shares at $4.17 ($5,267)
  3. 4 Open-market buy Director bought 1,576 shares at $3.69 ($5,815)
  4. 4 Open-market buy Director bought 1,424 shares at an average $3.60 ($5,123)
  5. 4 Open-market buy Chief Executive Officer bought 2,300 shares at an average $3.52 ($8,106)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Executive Officer bought 1,700 shares at an average $3.46 ($5,876)
  13. 4 Open-market buy Director bought 938 shares at $3.49 ($3,274)
  14. 4 Open-market buy Director bought 3,320 shares at an average $3.32 ($11,023)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 5,742 shares at an average $3.23 ($18,533)
  17. 4 Open-market buy Director bought 1,333 shares at $3.64 ($4,852)
  18. 4 Open-market buy Director bought 8,382 shares at an average $4.02 ($33,684)
  19. 4 Open-market buy Director bought 1,500 shares at $3.98 ($5,970)
  20. 4 Open-market buy Director bought 3,582 shares at $4.03 ($14,435)

Page 9 of 13 · 248 filings